Maria Seddighzadeh
Pfizer (Sweden)(SE)
Publications by Year
Research Areas
Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research, Monoclonal and Polyclonal Antibodies Research, Inflammatory Bowel Disease, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → A Candidate Gene Approach Identifies the TRAF1/C5 Region as a Risk Factor for Rheumatoid Arthritis(2007)278 cited
- → A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis(2010)276 cited
- → Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: Observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register cohorts(2010)252 cited
- → Predictors of response to methotrexate in early DMARD naïve rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial(2010)194 cited
- → Association of arthritis with a gene complex encoding C‐type lectin–like receptors(2007)109 cited
- → Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy(2010)92 cited
- → A Role for VAV1 in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis(2009)63 cited
- → Endometriosis and autoimmune disease: association of susceptibility to moderate/severe endometriosis with CCL21 and HLA-DRB1(2010)49 cited
- → Genetic variation in the transforming growth factor- 1 gene is associated with susceptibility to IgA nephropathy(2009)45 cited
- → Patterns of interaction between genetic and nongenetic attributes and methotrexate efficacy in rheumatoid arthritis(2011)45 cited